Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

It allows designers to create digital models of objects that can be manipulated and rendered in three dimensions. 3D modeling software is used to create and manipulate 3D models, and 3D animation ...

Get the full experience! Unlock access to all videos with the Unlimited Trains.com Membership.